Latest stories on RNTX
Rein Therapeutics, Inc. (RNTX) files 8-K
SEC 8-K50 · neutralgeneral
Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress
GlobeNewswire65 · bullishproduct/pr
Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress
Business Insider56 · neutralproduct/pr
Rein Therapeutics to Present at Upcoming September Investor Conferences
GlobeNewswire56 · neutralgeneral
Rein Therapeutics Receives Nasdaq Delisting Notice Over Bid Price
TipRanks28 · bearishgeneral
Rein Therapeutics, Inc. (RNTX) files 8-K
SEC 8-K34 · bearishgeneral
Rein Therapeutics granted Fast Track designation for LTI-03
The Fly63 · neutralproduct/pr
Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis
StockTitan63 · neutralproduct/pr
Rein Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Business Insider63 · neutralproduct/pr
Rein Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire63 · neutralearnings
Rein Therapeutics Announces Publication of Landmark LTI-03 Clinical Data in Nature Communications
StockTitan67 · bullishproduct/pr
Rein Therapeutics, Inc. (RNTX) files 8-K
SEC 8-K50 · neutralgeneral
Rein Therapeutics Announces Phase 2 RENEW Trial Now Enrolling Across All Five Countries
StockTitan63 · neutralproduct/pr
Rein Therapeutics Inc. (RNTX) Shareholder/Analyst Call Prepared Remarks Transcript
Seeking Alpha50 · neutralgeneral
Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom | RNTX Stock News
StockTitan63 · neutralproduct/pr